N-Methylpiperidine

N-Methylpiperidine

SCHEMBL6603929

CN1CCCCC1.CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N-Methyl Pyrrolidine (Nmp) SCHEMBL2343346 0.96
SCHEMBL414741 0.92 HRH3 (0.37)
SCHEMBL20124473 0.92 HRH3 (0.37)
SCHEMBL12316976 0.92 HRH3 (0.37)
SCHEMBL18807723 0.92 HRH3 (0.37)
SCHEMBL3793955 0.92 HRH3 (0.37)
N-Methylpiperidine SCHEMBL6660565 0.92 HRH3 (0.37)
N-Methylpiperidine SCHEMBL1920 0.92
SCHEMBL21960469 0.92 HRH3 (0.37)
SCHEMBL12952612 0.92 HRH3 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0905132-B1 Benzothiophenes LILLY CO ELI (US) 2004-08-04 EP disclosed
US-6060488-A ANTICARCINOGENIC AGENTS; POSTMENOPAUSAL CANCER OF BREASTS, UTERUS, CERVIX ELI LILLY AND COMPANY (US) 2000-05-09 US disclosed
WO-1999015521-A1 BENZOTHIOPHENES ELI LILLY AND COMPANY (US) 1999-04-01 WO disclosed
EP-0905132-A1 Benzothiophenes ELI LILLY AND COMPANY (US) 1999-03-31 EP disclosed